APA (7th ed.) Citation

L, K., S, A. S., R, C., B, H., B, I., F, N., . . . R, A. M. (2021). Anticancer activities of parthenolide in primary effusion lymphoma preclinical models. Molecular carcinogenesis, 60(8), 567. https://doi.org/10.1002/mc.23324

Chicago Style (17th ed.) Citation

L, Karam, Abou Staiteieh S, Chaaban R, Hayar B, Ismail B, Neipel F, Darwiche N, and Abou Merhi R. "Anticancer Activities of Parthenolide in Primary Effusion Lymphoma Preclinical Models." Molecular Carcinogenesis 60, no. 8 (2021): 567. https://doi.org/10.1002/mc.23324.

MLA (9th ed.) Citation

L, Karam, et al. "Anticancer Activities of Parthenolide in Primary Effusion Lymphoma Preclinical Models." Molecular Carcinogenesis, vol. 60, no. 8, 2021, p. 567, https://doi.org/10.1002/mc.23324.